(Press-News.org) https://doi.org/10.1016/j.apsb.2025.10.028
This new article publication from Acta Pharmaceutica Sinica B, discusses how structure-guided design of picomolar-level macrocyclic TRPC5 channel inhibitors with antidepressant activity.
Recent advances in ion channel structural biology have enhanced structure-based drug design, yet lipid-occupied binding pockets—often large and flat—remain a major hurdle for developing selective small molecules. TRPC5, a brain-enriched channel regulating depression and anxiety, is a promising therapeutic target, but current preclinical candidates suffer from moderate off-target effects. To address this, the authors of this article designed macrocyclic TRPC5 inhibitors using structure-guided macrocyclization, overcoming lipid-binding site challenges. Among these, JDIC-127 exhibited unprecedented potency with IC50 of 374 pmol/L—200-fold more potent than HC-070—and exceptional selectivity. Its specificity arises from interactions with unique structural features near the S5 and S6 helices of TRPC5, minimizing activity against related TRPC channels and other ion channels. This selective inhibition aligns with preclinical evidence supporting JDIC-127's potential in treating neuropsychiatric disorders. The study demonstrates how macrocycles stabilize ligand conformations, enhance affinity, and achieve selectivity in lipid-dominated binding sites. It also highlights the synergy between macrocyclic design, cryo-EM, and computational modeling to address longstanding obstacles in ion channel drug discovery. JDIC-127 serves as a proof-of-concept for the application of macrocyclization in ion channel pharmacology, offering a roadmap for developing innovative therapeutics targeting TRP channels and beyond, with implications for a wide range of diseases.
Keywords: TRPC5, Ion channel, Structure-based drug design, Macrocyclization, Selectivity, Cryo-EM, Antidepressant, Anxiolytic
Graphical Abstract: available at https://ars.els-cdn.com/content/image/1-s2.0-S2211383525007063-ga1_lrg.jpg
The macrocyclic compound JDIC-127 has demonstrated exceptional potency towards TRPC5, with an IC50 of 374 pmol/L, which is 200-fold more potent than HC-070, and exhibits significant selectivity against other TRP channels.
# # # # # #
The Journal of the Institute of Materia Medica, the Chinese Academy of Medical Sciences and the Chinese Pharmaceutical Association.
For more information please visit https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b/
Editorial Board: https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b/editorial-board
APSB is available on ScienceDirect (https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b).
Submissions to APSB may be made using Editorial Manager® (https://www.editorialmanager.com/apsb/default.aspx).
CiteScore: 24.3
Impact Factor: 14.6 (Top 6 journal in the category of Pharmacology and pharmacy)
JIF without self-citation: 13.8
ISSN 2211-3835
# # # # #
Tong Che, Yixiang Chen, Xinyu Cheng, Han Hu, Xiaoyun Wu, Yuting Zhang, Xiaoqiang Yang, Yinzhen Liu, Hui Liu, Weiwei Nan, Shuangyan Wan, Mingxing Yang, Bo Zeng, Jian Li, Jin Zhang, Bing Xiong, Structure-guided design of picomolar-level macrocyclic TRPC5 channel inhibitors with antidepressant activity, Acta Pharmaceutica Sinica B, Volume 16, Issue 1, 2026, Pages 371-386, ISSN 2211-3835, https://doi.org/10.1016/j.apsb.2025.10.028
END
https://doi.org/10.1016/j.apsb.2025.11.025
This new article publication from Acta Pharmaceutica Sinica B, discusses therapeutic drug monitoring of biologics in inflammatory bowel disease.
Therapeutic drug monitoring (TDM) has emerged as a valuable tool for optimizing the use of biologics in inflammatory bowel disease (IBD). However, variations in focus, methodology, and recommendations among relevant guidelines and consensuses have contributed to inconsistencies in their quality. This guideline synthesizes current evidence to standardize TDM of biologics in IBD and improve patient ...
A new global review highlights that tackling climate change requires more than funding or innovation alone. Researchers emphasize that meaningful climate action depends on the coordinated integration of financial systems, technological solutions, and governance reforms. The study presents a comprehensive framework designed to help countries, especially developing nations, implement effective and equitable climate strategies.
Climate change is increasingly threatening ecosystems, economies, and human well-being worldwide. ...
Scientists have discovered that cyanobacteria, microscopic organisms best known for driving harmful algal blooms, may play a major role in spreading antibiotic resistance genes in coastal environments. The findings highlight a previously overlooked link between natural nutrient cycling and the global challenge of antibiotic resistance.
Antibiotic resistance genes enable bacteria to survive exposure to antibiotics, posing serious risks to public health, agriculture, and ecosystem stability. While these genes are widely detected in aquatic environments, their biological drivers and ecological roles have remained poorly understood.
In a new study examining ...
Chestnut Hill, Mass. (2/6/2026) – Children across the globe engage in a constellation of behaviors that support cooperation, an action critical to the survival of the human species, a team of Boston College researchers report today in the journal Science Advances.
The team from Associate Professor of Psychology Katherine McAuliffe’s Cooperation Lab surveyed children in the urban United States, rural Uganda, Canada, and Peru, and the hunter-horticulturalist indigenous Shuar of Ecuador.
The researchers found there are cross-cultural regularities in some aspects of the development ...
How do children learn to cooperate with others? A new cross-cultural study suggests that the answer depends less on universal rules and more on the social norms surrounding the child.
In the study, researchers examined how more than 400 children ages five to 13 from the United States, Canada, Peru, Uganda and the Shuar communities of Ecuador behaved in situations involving fairness, trust, forgiveness and honesty. The team also surveyed children and adults in each community to understand what people believed was the “right” thing to do.
The ...
University of Phoenix announces the publication of “Bridging the AI skills gap: A blueprint for future‑proofing the workforce by including industry advisory councils for undergraduate environmental science program course redesign” in Industry and Higher Education. The article is authored by Jacquelyn Kelly, Ph.D., associate dean, College of General Studies; Dianna Gielstra, Ph.D., full-time faculty, Environmental Science Program, College of General Studies; Tomáš J. Oberding, Ph.D., full-time faculty, Environmental Science Program, College of General Studies, College of General Studies; Jim Bruno, MBA, associate dean, College of Business and ...
Antibiotic resistance (AR) has steadily accelerated in recent years to become a global health crisis. As deadly bacteria evolve new ways to elude drug treatments for a variety of illnesses, a growing number of “superbugs” have emerged, ramping up estimates of more than 10 million worldwide deaths per year by 2050.
Scientists are looking to recently developed technologies to address the pressing threat of antibiotic-resistant bacteria, which are known to flourish in hospital settings, sewage treatment areas, animal husbandry locations ...
NEW ORLEANS – Five Ochsner Health owned and affiliated hospitals have been named among Newsweek’s America’s Best-in-State Hospitals 2026. This honor is presented by Newsweek and Statista Inc., a leading statistics portal and industry ranking provider.
Ochsner Health’s dedication to top-quality patient care
“When our hospitals are recognized among the best in state, it is due to the dedication of our teams and the excellent care they provide. These individuals consistently put patients first through each step of the care journey. They live out Ochsner’s commitment ...
For the millions of people living with end‑stage kidney disease, hemodialysis is more than a medical procedure, it is a thrice‑weekly lifeline that keeps the body’s chemistry in balance. Yet even with decades of clinical experience and numerous technological advances, one stubborn challenge persists: determining how much fluid to remove during treatment without tipping a patient into dangerous instability. Too little fluid removal leaves patients overloaded, too much can trigger sudden drops in blood ...
Research Highlights:
For infants and toddlers who have had a stroke, a new treatment that restricted the use of their stronger arm and hand to encourage them to use their stroke-affected arm and hand, combined with high-dosage and a specific type of goal-directed therapy, led to immediate improvement in function and more skills gained.
The findings are based on 167 stroke survivors younger than 3 years old with marked impairment in using one arm. They were enrolled in the trial and randomly assigned to one of ...
